EXFO price target cut at National Bank on coronavirus concerns

The coronavirus has reached Canada, at least from a business perspective.

On Monday, EXFO (EXFO Stock Quote, Chart, News TSX:EXF) updated its revenue guidance. The company said it now expects Q2 revenue of $55-million (U.S.) instead of the $66-million (U.S.) to $71-million (U.S.) for the second quarter of fiscal 2020. The culprit? You guessed it.

“The safety of our employees, customers and partners is our top priority as the coronavirus public health emergency unfolds,” said CEO Philippe Morin in a press release. “Despite these temporary disruptions, we’re implementing the required actions to return to our normal course of business as quickly as possible. Demand drivers for fibre and 5G deployments remain robust on a global basis.”

National Bank Financial analyst Richard Tse said he expects this impact to be an extended one.

“The main reason for the reduced revenue outlook is the disruption in EXFO’s supply chain in China given preventive measures within the affected regions to contain the spread of the virus,” he said. “At this point, Management expects revenue to accelerate in upcoming quarters as operations return to full capacity. However, given the uncertain backdrop for the virus, it’s very difficult to make a call as to when that ramp will occur. ”

In a research update to clients today, Tse maintained his “Sector Perform” rating on EXFO, but lowered his one-year price target on the stock from (US) $4.25 to $3.75, which implied a return of negative 6 per cent at the time of publication.

The analyst expects EXFO will post EBITDA of (All figures USD) $28.0-million on revenue of $273.8-million in fiscal 2020. He thinks those numbers will improve to EBITDA of $32.6-million on a topline of $308.2-million the following year.

“In our view, we’ve been pointing to a balanced risk-to-reward profile for EXFO in light of the early stage of 5G deployments,” the analyst added. “With the growing uncertainty around the spread of the virus and the supply chain constraints in China for EXFO, this pushes the risk profile higher in the short term. We’re maintaining our Sector Perform rating with a revised DCF-based target of US$3.75 (was US$4.25), which implies a valuation of 7.4x EV/EBITDA on our F20E (was 7.1x). “

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: exf
Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

WELL Health inks five-year deal with Microsoft

It's become one of the biggest players in the Canadian healthcare space, now WELL Health (WELL Health Stock Quote, Chart,… [Read More]

18 hours ago

Is Thomson Reuters stock a buy right now?

Its stock has made a since last October, but is there more upside left in Thomson Reuters (Thomson Reuters Stock… [Read More]

19 hours ago

Is GOOGL still a buy?

Following a widely applauded first quarter beat, Roth MKM analyst Rohit Kulkarni has maintained his "Buy" rating on Alphabet (Alphabet… [Read More]

2 days ago

NLH has 173% upside, Echelon says

Following an acquisition, Echelon Capital Markets analyst Stefan Quenneville has maintained his "Buy" rating on Nova Leap Health (Nova Leap… [Read More]

2 days ago

Shopify upgraded to “Buy” at Citi

The stock has been flat since November, but Citi analyst Tyler Radke thinks there is now money to be made… [Read More]

2 days ago

Sabio has 400% upside, Eight Capital says

Following the company's fourth quarter results, Eight Capital analyst Kiran Sritharan has maintained his "Buy" rating on Sabio Holdings (Sabio… [Read More]

5 days ago